Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction Associated with Neurodegenerative Diseases.
以 GLP-1 和 NMDA 受體為交火點的洞穴小體:創新治療與神經退行性疾病相關的認知功能障礙。
Molecules 2024-08-29
Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus.
糖尿病認知衰退和失智症治療中胰高血糖素樣肽-1受體激動劑的潛在作用。
Int J Mol Sci 2023-08-07
Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists.
針對神經退化中的氧化還原失衡:特徵化 GLP-1 受體激動劑的角色。
Theranostics 2023-10-05
GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer's Disease Therapy.
GLP-1類似物、SGLT-2和DPP-4抑制劑:阿茲海默症治療的希望三合一。
Biomedicines 2023-11-28
GLP-1/Sigma/RAGE receptors: An evolving picture of Alzheimer's disease pathology and treatment.
GLP-1/Sigma/RAGE 受體:阿茲海默症病理和治療的演變圖景。
Ageing Res Rev 2024-01-16
Investigating the Glucagon-like Peptide-1 and Its Receptor in Human Brain: Distribution of Expression, Functional Implications, Age-related Changes and Species Specific Characteristics.
探討人腦中的葡萄糖樣肽-1及其受體:表現分佈、功能意義、年齡相關變化和物種特異特徵的研究。
Basic Clin Neurosci 2023-12-11
The Association of Circulating Glucagon-Like Peptide-1 with Cognitive Functions and Biomarkers in Alzheimer's Disease.
循環胰高血糖素樣肽-1與阿茲海默症認知功能和生物標誌物的關聯。
J Alzheimers Dis 2024-05-17
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects.
糖尿病藥物中的胰高血糖素樣肽-1受體激動劑和鈉-葡萄糖共轉運蛋白2抑制劑對心臟衰竭和認知障礙的保護作用:潛在的保護效應機制。
Front Pharmacol 2024-07-01
Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration.
基於胰高血糖素樣肽的多重激動劑肽在神經退行性疾病的細胞模型中具有神經保護和抗炎作用。
Biomolecules 2024-07-27